Larvol Delta - eVOLVERCC02-A-Study-to-Investigate-the-Efficacy-and-Safety-of-Volrustomig--Casdatifan-vs-Nivolumab--Ipilimumab-as-1L-Treatment-for-Advanced-ccRCC

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

casdatifan (AB521) - Arcus Biosciences

volrustomig (MEDI5752) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT07000149

Aug 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next